China Shineway Pharmaceutical Group Limited (2877.HK)
HKD 8.7
(-0.57%)
HKD 8.7
(-0.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.58 Billion CNY | -11.33% |
| 2022 | -5.01 Billion CNY | -19.76% |
| 2021 | -4.19 Billion CNY | -18.02% |
| 2020 | -3.55 Billion CNY | -0.27% |
| 2019 | -3.54 Billion CNY | 1.94% |
| 2018 | -3.61 Billion CNY | -2.24% |
| 2017 | -3.53 Billion CNY | -9.76% |
| 2016 | -3.21 Billion CNY | -13.88% |
| 2015 | -2.82 Billion CNY | -13.59% |
| 2014 | -2.48 Billion CNY | -38.85% |
| 2013 | -1.79 Billion CNY | 19.01% |
| 2012 | -2.21 Billion CNY | -1.82% |
| 2011 | -2.17 Billion CNY | 7.5% |
| 2010 | -2.34 Billion CNY | -1.33% |
| 2009 | -2.31 Billion CNY | -46.2% |
| 2008 | -1.58 Billion CNY | 5.53% |
| 2007 | -1.67 Billion CNY | -6.1% |
| 2006 | -1.58 Billion CNY | -17.39% |
| 2005 | -1.34 Billion CNY | -17.53% |
| 2004 | -1.14 Billion CNY | -288.69% |
| 2003 | -294.98 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | -5.58 Billion CNY | 0.0% |
| 2023 Q2 | -5.06 Billion CNY | 0.0% |
| 2023 FY | -5.58 Billion CNY | -11.33% |
| 2022 FY | -5.01 Billion CNY | -19.76% |
| 2022 Q2 | -4.45 Billion CNY | 0.0% |
| 2022 Q4 | -5.01 Billion CNY | 0.0% |
| 2021 Q2 | -4.13 Billion CNY | 0.0% |
| 2021 FY | -4.19 Billion CNY | -18.02% |
| 2021 Q4 | -4.19 Billion CNY | 0.0% |
| 2020 FY | -3.55 Billion CNY | -0.27% |
| 2020 Q4 | -3.55 Billion CNY | 0.0% |
| 2020 Q2 | -3.46 Billion CNY | 0.0% |
| 2019 FY | -3.54 Billion CNY | 1.94% |
| 2019 Q2 | -3.54 Billion CNY | 0.0% |
| 2019 Q4 | -3.54 Billion CNY | 0.0% |
| 2018 Q4 | -3.61 Billion CNY | 0.0% |
| 2018 FY | -3.61 Billion CNY | -2.24% |
| 2018 Q2 | -3.59 Billion CNY | 0.0% |
| 2017 Q4 | -3.53 Billion CNY | 0.0% |
| 2017 Q2 | -3.43 Billion CNY | 0.0% |
| 2017 FY | -3.53 Billion CNY | -9.76% |
| 2016 FY | -3.21 Billion CNY | -13.88% |
| 2016 Q4 | -3.21 Billion CNY | 0.0% |
| 2016 Q2 | -2.95 Billion CNY | 0.0% |
| 2015 FY | -2.82 Billion CNY | -13.59% |
| 2015 Q4 | -2.82 Billion CNY | 0.0% |
| 2015 Q2 | -2.95 Billion CNY | 0.0% |
| 2014 Q4 | -2.48 Billion CNY | 0.0% |
| 2014 FY | -2.48 Billion CNY | -38.85% |
| 2014 Q2 | -1.87 Billion CNY | 0.0% |
| 2013 Q2 | -2.28 Billion CNY | 0.0% |
| 2013 FY | -1.79 Billion CNY | 19.01% |
| 2013 Q4 | -1.79 Billion CNY | 0.0% |
| 2012 Q4 | -2.21 Billion CNY | 0.0% |
| 2012 FY | -2.21 Billion CNY | -1.82% |
| 2012 Q2 | -2.13 Billion CNY | 0.0% |
| 2011 Q2 | -2 Billion CNY | 0.0% |
| 2011 Q4 | -2.17 Billion CNY | 0.0% |
| 2011 FY | -2.17 Billion CNY | 7.5% |
| 2010 Q4 | -2.34 Billion CNY | 0.0% |
| 2010 FY | -2.34 Billion CNY | -1.33% |
| 2010 Q2 | -2.15 Billion CNY | 0.0% |
| 2009 FY | -2.31 Billion CNY | -46.2% |
| 2009 Q4 | -2.31 Billion CNY | 0.0% |
| 2008 FY | -1.58 Billion CNY | 5.53% |
| 2007 FY | -1.67 Billion CNY | -6.1% |
| 2006 FY | -1.58 Billion CNY | -17.39% |
| 2005 FY | -1.34 Billion CNY | -17.53% |
| 2004 FY | -1.14 Billion CNY | -288.69% |
| 2003 FY | -294.98 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | -2059.793% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 374.992% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 94101.514% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 1952.996% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -29248.934% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 18154.317% |
| Essex Bio-Technology Limited | -219.22 Million HKD | -2448.682% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 2281.2% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 1579.927% |
| SSY Group Limited | 1.71 Billion HKD | 426.08% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -75416.286% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 1755.825% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 110.96% |